Epidermal growth factor

Epidermal growth factor (EGF) is a protein that stimulates cell growth, cell proliferation, and cell differentiation by binding to its receptor, EGFR (Epidermal Growth Factor Receptor). EGF is a member of the growth factor family and plays a crucial role in the regulation of cell growth, proliferation, and differentiation.
Discovery[edit]
EGF was first discovered by Stanley Cohen in 1962. Cohen's work on EGF earned him the Nobel Prize in Physiology or Medicine in 1986, which he shared with Rita Levi-Montalcini for their discoveries of growth factors.
Structure[edit]
EGF is a small polypeptide consisting of 53 amino acids and has a molecular weight of approximately 6.2 kDa. The structure of EGF includes three disulfide bonds that are essential for its biological activity.
Function[edit]
EGF functions by binding to the epidermal growth factor receptor on the cell surface. This binding triggers a cascade of downstream signaling pathways, including the MAPK/ERK pathway, the PI3K/AKT pathway, and the JAK/STAT pathway. These pathways lead to various cellular responses such as DNA synthesis, cell proliferation, and differentiation.
Role in Medicine[edit]
EGF has significant implications in medicine, particularly in the fields of oncology and wound healing. Overexpression of EGF and EGFR has been linked to various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Targeting the EGF/EGFR pathway is a therapeutic strategy in cancer treatment, with drugs such as gefitinib and erlotinib being used as EGFR inhibitors.
In wound healing, EGF promotes the regeneration of the epidermis and accelerates the healing process. EGF-containing topical treatments are used to enhance the healing of burns, ulcers, and other skin injuries.
Clinical Applications[edit]
EGF has been used in various clinical applications, including:
- Cancer therapy: Targeting EGFR with specific inhibitors.
- Wound healing: Topical application of EGF to promote skin regeneration.
- Cosmetic industry: EGF is used in anti-aging products to stimulate skin cell renewal.
See also[edit]
References[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian